Potent, selective and competitive AMPA receptor antagonist. Neuroprotective and anticonvulsant; active in vivo
. NBQX disodium salt
(Cat. No. 1044) also available.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold with the permission of Novo Nordisk A/S
Other Product-Specific Information:
The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX) in a rat focal ischaemia model.
Gill et al.
Brain Res., 1992;580:35
Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
Namba et al.
Brain Res., 1994;638:36
The pharmacology of AMPA receptors and their antagonists.
Sheardown et al.
Pharmacological characterization of non-NMDA subtypes of glutamate receptors in the neonatal rat hemisected spinal cord in vitro.
Zeman and Lodg
The citations listed below are publications that use Tocris products. Selected citations for NBQX include:
Showing Results 1 - 10 of 141